Literature DB >> 30222017

A practical algorithm for topical treatment of atopic dermatitis in the Middle East emphasizing the importance of sensitive skin areas.

Ashraf M Reda1, Ayman Elgendi2, Ahmed Ismail Ebraheem3, Mohammed S Aldraibi4, Mohammed Saleh Qari5, Magdy Mohammad R Abdulghani4, Thomas Luger6.   

Abstract

Background There is a need for safe, effective treatment for atopic dermatitis (AD) in the Middle East. Objective To propose a practical algorithm for the treatment of AD throughout the Middle East. Methods An international panel of six experts from the Middle East and one from Europe developed the algorithm. The practical treatment guide was based on a review of published guidelines on AD, an evaluation of relevant literature published up to August 2016 and local treatment practices. Results Patients with an acute mild-to-moderate disease flare on sensitive body areas should apply the topical calcineurin inhibitor (TCI), pimecrolimus 1% cream twice daily until clearance. For other body locations, a TCI, either pimecrolimus 1% cream, tacrolimus 0.03% ointment in children or 0.1% ointment in adults, should be applied twice daily until clearance. Emollients should be used as needed. Patients experiencing acute severe disease flares should apply a topical corticosteroid (TCS) according to their label for a few days to reduce inflammation. After clinical improvement, pimecrolimus for sensitive skin areas or TCIs for other body locations should be used until there is a complete resolution of lesions. Conclusions These recommendations are expected to optimize AD management in patients across the Middle East.

Entities:  

Keywords:  Atopic dermatitis; Middle East; algorithm; topical calcineurin inhibitors

Mesh:

Substances:

Year:  2018        PMID: 30222017     DOI: 10.1080/09546634.2018.1524823

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  6 in total

1.  Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies.

Authors:  Xiaohua Gong; Xuejun Chen; Michael E Kuligowski; Xing Liu; Xiang Liu; Evan Cimino; Ryan McGee; Swamy Yeleswaram
Journal:  Am J Clin Dermatol       Date:  2021-05-12       Impact factor: 7.403

2.  Practical Recommendations for the Topical Treatment of Atopic Dermatitis in South and East Asia.

Authors:  David Luk; Kam Lun Ellis Hon; Maria Victoria C Dizon; Kin-Fon Leong; Yong-Kwang Tay; Mark Jean-Aan Koh; Nisha Suyien Chandran; Siriwan Wananukul; Susheera Chatproedprai; Thomas Luger
Journal:  Dermatol Ther (Heidelb)       Date:  2020-12-12

3.  Experts' Consensus on the Use of Pimecrolimus in Atopic Dermatitis in China: A TCS-Sparing Practical Approach.

Authors:  Zuotao Zhao; Xing-Hua Gao; Wei Li; Hua Wang; Yunsheng Liang; Jianping Tang; Xu Yao; Hua Zhao; Thomas Luger
Journal:  Dermatol Ther (Heidelb)       Date:  2022-03-21

4.  Management of Atopic Dermatitis in Adults in Saudi Arabia: Consensus Recommendations from the Dermatological Expert Group.

Authors:  Abdullah Alakeel; Afaf Al Sheikh; Ali A Alraddadi; Khalid Mohammed Alattas; Maha Aldayel; Mohammed Abdulaziz Alajlan; Mohammed Al-Haddab; Mohammad Almohideb; Mohamed Fatani; Issam R Hamadah; Ruaa Alharithy; Yousef Binamer; Kim Papp; Ahmed Elaraby
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-07-26

Review 5.  Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review.

Authors:  Yuri I Lopez Carrera; Anwar Al Hammadi; Yu-Huei Huang; Lyndon J Llamado; Ehab Mahgoub; Anna M Tallman
Journal:  Dermatol Ther (Heidelb)       Date:  2019-10-24

6.  Paediatric atopic eczema (atopic dermatitis) in South Africa: A practical algorithm for the management of mild-to-moderate disease in daily clinical practice.

Authors:  Susanna M Kannenberg; Sarah Karabus; Willem I Visser; Jamilabibi Aboobaker; Magdalena M Kriel; Michael Levin; Basil Magigaba; Ahmed Manjra; Rupesh Misra; Pholile Mpofu; Azwitamisi Tshigabe; Thomas Luger
Journal:  S Afr Fam Pract (2004)       Date:  2020-11-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.